---
New recommendations could spur manufacturers of drugs that receive accelerated approval to complete post-market confirmatory clinical trials faster.
Source: The Commonwealth Fund: Blog - Category: International Medicine & Public Health Authors: Edwin Park Source Type: blogs
More News: Blogging | International Medicine & Public Health